Class Year
2022
Document Type
Poster
Date of Creation
Fall 2018
Department 1
First Year Seminar
Department 2
Chemistry
Abstract
Despite the human immune system, cancer thrives in an extremely hostile environment. Cancer is the second most common cause of death in the U.S. with about 600,000 deaths every year, and cancer is expected to surpass heart disease as the most common cause of death in the U.S. Immune checkpoint inhibitors are a novel and promising therapeutic for treating cancer in its late stages.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Cherubino, Matthew A., "Immune Checkpoints in Cancer Treatment" (2018). Student Publications. 677.
https://cupola.gettysburg.edu/student_scholarship/677
Comments
Created for FYS 155-2: Cancer in Society: A War Against Immortality and presented at the 2019 Celebration of Academic First-Year Engagement Symposium.